US - HealthQuill

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

by HealthQuill
July 17, 2024
0 Comments

Pharmacy benefit managers, who handle about 95% of US prescriptions, are inflating drug costs and squeezing independent pharmacies, according to a report.

Drugs Health Pharma

Pharmacy benefit managers in the US wielding ‘enormous power’: FTC report

Pharmacy benefit managers, who handle about 95% of US prescriptions, are inflating drug costs and squeezing independent pharmacies, according to a report.

by HealthQuill
July 10, 2024
0 Comments

The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic avian influenza.

Drugs Health Pharma

Bird flu detected in a fourth person in the US, health agency CDC says

The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic.

by HealthQuill
July 4, 2024
0 Comments

The USFDA has rejected a Biologics License Application from Daiichi Sankyo and Merck & Co., seeking accelerated approval of patritumab deruxtecan to treat a type of lung cancer.

Drugs Health Pharma

FDA rejects Daiichi, Merck, antibody-drug conjugate application

The USFDA has rejected a Biologics License Application from Daiichi Sankyo and Merck & Co., seeking accelerated approval of patritumab deruxtecan to treat.

by HealthQuill
June 28, 2024
0 Comments

Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic disease drugs, according to a company statement.

Drugs Health Pharma

Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina

Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.

by HealthQuill
June 25, 2024
0 Comments

The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by Novo Nordisk and weight-loss medication Wegovy.

Drugs Health Pharma

WHO issues medical alert on falsified weight-loss, diabetic drugs

The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by.

by HealthQuill
June 21, 2024
0 Comments

Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.

Drugs Health Pharma

Roche to pay $42 million to Ascidian to make RNA exon editing drugs

Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.

by HealthQuill
June 18, 2024
0 Comments

Israel’s Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to treat a rare hormonal disorder.

Drugs Medical Pharma

Israel’s Teva Pharmaceuticals sue Corcept, Optime over drug monoploy

Israel’s Teva Pharmaceuticals has sued US-based Corcept Therapeutics and Optime Care Inc., a specialty pharma, for monopolising the market for a drug used to.